Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC
Combined Modality Therapy of Cancer
Combined Modality Therapy in the Upfront Treatment of Patients with Primary Central Nervous System Lymphoma: A Systematic Review
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy
Surfactant and Combined-Modality Therapies for
Radiation and Combined Modality Therapy
Combined modality therapy for NSCLC
